CB1/2 agonist 3 (compound 52), a potent non-selective cannabinoid ligand, acts as a competitive agonist for the CB1 and CB2 receptors, exhibiting agonistic activity by binding to the human CB1 and CB2 receptors with Ki values of 5.9 nM and 3.5 nM, respectively [1].